Correlation Between Terns Pharmaceuticals and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Capricor Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Capricor Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Capricor Therapeutics
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Terns and Capricor is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Capricor Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.85 times more return on investment than Capricor Therapeutics. However, Terns Pharmaceuticals is 1.18 times less risky than Capricor Therapeutics. It trades about -0.17 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 667.00 in Terns Pharmaceuticals on August 26, 2024 and sell it today you would lose (88.00) from holding Terns Pharmaceuticals or give up 13.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Capricor Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Capricor Therapeutics |
Terns Pharmaceuticals and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Capricor Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Akari Therapeutics PLC | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets |